Table 2:
Response to treatment, time to progression, and survival in relation to EGFR mutations.
EGFR mutations
Positive
Negative
Unknown
All
Response to treatment
CR
4
—
1
5
PR
4
2
3
9
SD
—
6
2
8
Progression
—
2
—
2
Time to progression (months)
Median (95% CI)
21.5 (14.8–27.2)
5.0 (0.9–9.1)
5.0 (3.9–4.1)
13.4 (5.4–20.6)
Survival (months)
Median (95% CI)
24.2
7.0 (0.1–13.9)
11.0
23.0 (10.9–35.2)